Skip to content

Pregnancy Chances in Classic Galactosemia

Pregnancy Chances in Classic Galactosemia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02091128
Enrollment
85
Registered
2014-03-19
Start date
2014-03-31
Completion date
2016-09-30
Last updated
2016-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Galactosemias, Primary Ovarian Insufficiency

Brief summary

With this study, in which the incidence of pregnancy in classic galactosemia patients is studied, we aim to provide new insights to improve counselling. Our hypothesis is that the chance that a galactosemic woman with POI becomes pregnant is higher than the 5-10% that has been reported for women with POI due to other causes. Chance of spontaneous pregnancy will be evaluated through semi standardized interview in women with classic galactosemia aged 18 years or older. During the interview, questions will be asked regarding fertility and pregnancy.

Interventions

None listed

Sponsors

Maastricht University Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Classic galactosemia diagnosed by GALT enzyme activity assay or GALT-gene mutation analysis * Eighteen years of age or older * Diagnosed with POI defined as symptoms of hypergonadotrophic hypogonadism measured by serum concentrations of FSH and estradiol * Capable of giving informed consent

Exclusion criteria

* Any known congenital or acquired disease or disorder negatively affecting pubertal development and/or fertility.

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy incidence despite POI diagnosisday 1Will be assessed during semi-standardized interview

Secondary

MeasureTime frameDescription
Whether women have tried to conceiveday 1Will be assessed during semi-standardized interview
Time to pregnancy (in case a participant has been pregnant)day 1Will be assessed during semi-standardized interview
Menstrual historyday 1Will be assessed during semi-standardized interview
Hormonal replacement therapy usageday 1Will be assessed during semi-standardized interview

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026